Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Oct 11.
Published in final edited form as: Cancer Prev Res (Phila). 2018 Sep;11(9):593. doi: 10.1158/1940-6207.CAPR-18-0235

Retraction: Gambogic Acid Inhibits STAT3 Phosphorylation through Activation of Protein Tyrosine Phosphatase SHP-1: Potential Role in Proliferation and Apoptosis

PMCID: PMC6181137  NIHMSID: NIHMS991845  PMID: 30181122

This article (1) has been retracted at the request of the editors. An internal journal investigation determined that the pSTAT3 immunoblot in Fig. 5C appears to have been inappropriately digitally manipulated. In addition, an image of the same field of cells was used to represent the effects of SHP-1 siRNA under two experimental conditions (control and gambogic acid treatments) in Fig. 5D. The original research records related to Fig. 5D were not available during an institutional investigation.

A copy of this Retraction Notice was sent to the last known email addresses for all four authors. Two authors (S. Prasad and B.B. Aggarwal) did not agree to the retraction; the two remaining authors (M.K. Pandey and V.R. Yadav) did not respond.

Reference

  • 1.Prasad S, Pandey MK, Yadav VR, Aggarwal BB. Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis. Cancer Prev Res 2011;4:1084–94. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

RESOURCES